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Background & Aims: Recent data support an important
role of resident luminal bacteria in experimental colitis.
We determined how altered cecal bacterial loads influ-
ence colitis and gastritis. Methods: A cecal self-filling
blind loop (SFBL) was created or the cecum was
excluded from the fecal stream in specific pathogen–
free HLA-B27 transgenic (TG) rats with early colitis and
in nontransgenic (nonTG) littermates; controls under-
went sham operation (SHAM). Luminal bacterial con-
centrations were determined by culture and counting
chamber. Results: TG rats with SFBL had more severe
cecal inflammation and leukocytosis than TG SHAM
controls. TG excluded rats with low cecal bacterial
loads had no cecal inflammation and less colitis and
gastritis than SHAM controls, despite having normal
distal colonic and gastric bacterial concentrations.
Metronidazole attenuated cecal inflammation and elimi-
nated Bacteroides in SFBL TG rats. NonTG SFBL rats
had mild cecal inflammation and no gastritis and
colitis. The ratio of total anaerobic to aerobic bacteria
was 1000-fold greater in SFBL than in SHAM rats, with
a 10,000-fold increased ratio of Bacteroides spp. to
aerobes. Conclusions: The luminal bacterial load and
composition determines the activity of cecal inflamma-
tion in genetically susceptible hosts. Lowering cecal
bacterial concentrations can diminish inflammation in
remote organs.
Extensive data support an important role for normalluminal bacteria in inflammatory bowel disease,
especially Crohn’s disease and experimental enterocoli-
tis.1–3 Resident bacteria have been implicated in the
pathogenesis of indomethacin-,4 carrageenan-,5 and dex-
tran sulfate sodium–induced6 intestinal inflammation, as
well as spontaneous colitis in interleukin (IL)-22/2,7
IL-102/2,8 CD45RBhigh reconstituted severe combined
immunodeficient (SCID) mice,9 and C3H/HeJBir
mice.10,11 In a recent study we showed the essential
influence of resident bacteria on the spontaneous colitis
and gastritis in HLA-B27/b2 microglobulin transgenic
(TG) Fischer rats.12 The onset of spontaneous colitis
and gastritis in TG rats normally begins at 2 months of
age with a 100% incidence of nonbloody diarrhea by 3–4
months.13,14 In a sterile environment these animals do
not develop colitis, gastritis, or arthritis.12,15 However,
when germfree rats were transferred into a specific
pathogen–free (SPF) environment, all TG rats had histo-
logical and biochemical evidence of active colitis and
gastritis after 4 weeks, although diarrhea was not evident
at this time.12
Additional data show that altering bacterial popula-
tions influences the degree of intestinal and extraintesti-
nal inflammation. Decreasing luminal bacterial concentra-
tions, especially of anaerobic bacteria, can be beneficial in
both clinical and experimental enterocolitis. Crohn’s
colitis and ileocolitis respond to several antibiotics includ-
ing metronidazole,16 which is selectively active against
anaerobic bacteria. Metronidazole also attenuates chronic
experimental intestinal inflammation in the indometha-
cin and carrageenan models4,17 and in HLA-B27 TG
rats.18 Bowel rest, leading to long-term reduction of
luminal bacteria, is used to treat severe Crohn’s dis-
ease.19–21 However, anaerobic bacterial overgrowth in
bypassed jejunoileal segments for morbid obesity leads to
systemic inflammation.22 Experimental small intestinal
anaerobic bacterial overgrowth in a jejunal self-filling
blind loop (SFBL) can induce hepatobiliary inflammation
and reactivate quiescent arthritis in genetically suscep-
tible Lewis rats.23,24 In both human and rat bacterial
overgrowth models, broad-spectrum antibiotics or metro-
nidazole treat systemic manifestations.23,25–27 These re-
sults convincingly show that anaerobic bacteria play an
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important role in induction of colitis and extraintestinal
manifestations in genetically susceptible hosts. Our re-
cent data support this hypothesis and show that all
bacteria do not have equal abilities to induce gastrointes-
tinal inflammation. Gnotobiotic B27 TG rats, colonized
with 6 different obligate and facultative anaerobic bacte-
ria including Streptococcus faecium, Streptococcus avium, Pepto-
streptococcus productus, Escherichia coli, Eubacterium contortum,
and Bacteroides vulgatus developed much more active
colitis and gastritis than littermates colonized with the
same bacteria without B. vulgatus.12
This study shows how alterations in the autologous
cecal bacterial composition and load influence the degree
of gastrointestinal inflammation in HLA-B27 TG rats,
without using antibiotics or selected heterologous bacte-
ria. Attention was focused on Bacteroides spp. because our
previous observations in gnotobiotic rats showed a domi-
nant role for these species.12
Materials and Methods
Animals
A colony of HLA-B27 TG rats and nontransgenic
(nonTG) littermates13 originally obtained from Dr. Joel D.
Taurog (Southwestern Medical School, Dallas, TX) was derived
into a sterile environment, populated with SPF bacteria, then
housed and maintained in an SPF environment.12
Experimental Design
TG rats (N 5 21) raised in an SPF environment were
divided into 3 groups at 2 months of age, when colitis first
becomes evident. In one group a cecal SFBL was created as
described later, in the second group the cecum was excluded
from the fecal stream (EX), and the third group was sham
operated (SHAM). NonTG littermates (n 5 11) were SHAM or
SFBL operated and served as negative controls. All rats were
monitored weekly for clinical evidence of diarrhea and arthritis.
One month after surgery, at the age of 3 months, all rats were
killed by CO2 asphyxiation. Anticoagulated cardiac blood was
obtained for white blood cell (WBC) counts. The cecum and
colon were inspected grossly in a blinded fashion for evidence of
intestinal thickness and scored on a validated scale ranging
from 0 to 41 as previously described.12 The cecum, stomach,
and right colon were fixed in 10% buffered formalin for
histological evaluations. Tissues from the transverse colon were
snap-frozen in isopentane for protein assays.
In a separate experiment, we treated TG SFBL rats with
metronidazole, 40 mg · kg21 · day21, in drinking water.
Treatment was begun at the age of 8 weeks, and surgery was
performed at 10 weeks. Metronidazole-treated rats (n 5 4) and
water controls (n 5 4) were killed at 14 weeks of age. Cecal
tissue was removed for histology.
All studies were performed with the approval of the
University of North Carolina Animal Care and Use Commit-
tee.
Creation of a Cecal SFBL
Cecal SFBLs were created in TG rats (n 5 8) and
nonTG littermates (n 5 6) at 2 months of age. Anesthesia was
induced using 40 mg/kg intramuscular ketamine and 0.75
mg/kg acepromazine. After a midline incision, the cecum was
ligated at the cecal-colonic junction using a 4.0 silk suture
(Figure 1). Continuity of the fecal stream was accomplished by
a side-to-side anastomosis between the terminal ileum and the
transverse colon, using 6.0 Vicryl sutures (Ethicon Inc.,
Sommerville, NJ). SHAM operation (TG, N 5 5; nonTG, N 5
5) included a laparotomy and external manipulation of the
cecum, but no ligation or anastomosis.
Exclusion of the Cecum
Surgery was performed on TG rats (n 5 8) at 2 months
of age. After anesthesia and midline incision the cecum was
separated from the right colon and terminal ileum (Figure 1).
The section of the terminal ileum connected to the cecum was
ligated using a 4.0 silk suture. A colostomy was performed
using the colonic end of the cecum. The transected right colon
was ligated and an end-to-side anastomosis with the terminal
ileum was created using 6.0 Vicryl sutures.
Determination of Bacterial Concentrations
The cecum, colon, jejunum, ileum, and stomach of TG
and nonTG rats (SFBL, EX, and SHAM) were removed and
Figure 1. Surgical procedures to create an SFBL and exclusion of the
cecum with a colostomy (EX). Surgical procedures were performed on
2-month-old TG Fischer rats and nonTG littermates. C, cecum; TI,
terminal ileum; TC, transverse colon; DC, descending colon.
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immediately placed into an anaerobic isolator. One milliliter of
cecal contents was taken, weighed, and serially diluted in
phosphate-buffered saline or prereduced thioglycolate broth.
From every 10-fold dilution, 100 µL were plated on modified
Bryant’s medium 10 (MM10) agar or prereduced anaerobically
sterilized (PRAS) agar plates in an anaerobic 5% CO2, 10% H2,
and 85% N2 atmosphere. Aerobic culture was performed using
enriched brain heart infusion (BHI) agar or blood agar plates.
Colonies were counted after 2 (aerobic) and 6 (anaerobic) days
of incubation at 37°C. Bacteroides spp. were selectively grown
on Bacteroides Bile Esculin (BBE) Agar under anaerobic condi-
tions. Morphology was determined by Gram stain. Total
bacterial concentrations were determined on serial dilutions
with phase-contrast microscopy using a Petroff–Hauser count-
ing chamber. Identification of presumed Bacteroides spp. was
performed according to standard procedures.28 Results were
normalized for stool dry weights.
Histology
Tissues were prepared as previously described.12 A
validated histological inflammatory score ranging from 0 to 41
was used for blinded evaluation of colonic and gastric inflamma-
tion.12
Rat IL-1b ELISA
We measured IL-b protein concentrations in the cecal
tissue by enzyme-linked immunosorbent assay (ELISA) as
previously described,12 using antibodies that were provided by
Dr. S. Poole, National Institute of Biological Standards and
Controls, Hertfordshire, England.
Statistical Analysis
Statistics were performed using the analysis of variance
and the Student t test for comparison between the groups and
the x2 test for nominal data. Significance was considered to be
P , 0.05. All data are presented as mean 6 SEM.
Results
Clinical Features
One hundred percent of the TG SFBL rats had
diarrhea 3–4 weeks after surgery compared with 0% of
the SHAM and EX groups (P , 0.0005). There were no
differences in weight gain in the various groups. One TG
rat with SFBL developed active arthritis, but no arthritis
was observed in the SHAM and EX groups. NonTG rats
had no evidence of diarrhea or arthritis.
Cecal Inflammation
The blinded gross gut score of the cecum (Figure
2) was significantly increased in the TG SFBL compared
with TG SHAM rats (3.6 6 0.1 vs. 1.6 6 0.2; P ,
0.0001). The predominant visible abnormality was thick-
ening of the large intestine, which was more evident in
the cecum than in the colon. There were no macroscopic
signs of inflammation in the TG EX and nonTG SHAM
groups (0.1 6 0.1 for both; P , 0.0001 vs. TG SHAM).
Histological inflammation in the lamina propria of the
cecum of TG SHAM rats (Figure 3A) was characterized
by diffuse infiltration of predominantly mononuclear
cells and scattered eosinophils but few neutrophils,
thickening of the mucosa with crypt hyperplasia, few
scattered crypt abscesses, and rare superficial ulcerations.
Inflammation was confined to the mucosa. Mucosal
inflammation was increased in TG SFBL rats and ex-
tended to the submucosa compared with TG SHAM
controls (Figure 3C and D). Seventy-five percent of TG
SFBL rats had submucosal inflammation vs. 0% of TG
SHAM rats (P , 0.01). More aggressive cecal inflamma-
tion in SFBL TG rats was confirmed by blinded histologi-
cal inflammatory scores (3.6 6 0.2 vs. 2.5 6 0; P ,
0.005; Figure 2). There was almost no evidence of cecal
inflammation in TG EX rats (Figure 3B), as confirmed by
the lack of difference in histological scores of TG EX and
nonTG SHAM rats (0.5 6 0.2 vs. 0.2 6 0.1; both P ,
0.0001 vs. TG SHAM; Figure 2).
IL-1b protein concentrations in the cecal tissue (Figure
2) of TG EX were significantly reduced compared with
TG SHAM (138.0 6 32.9 vs. 417.9 6 69.5 ng/g tissue;
P , 0.01). However, there were no differences evident
between TG SHAM and SFBL (442.9 6 100.5) or
between TG EX and nonTG SHAM (75.3 6 17.8)
groups.
NonTG SFBL rats had mild-to-moderate grossly de-
Figure 2. Quantitation of cecal inflammation in HLA-B27/b2 micro-
globulin TG rats exposed to variable bacterial loads. Blinded gross (h)
and histological (I) evaluations showed significantly increased inflam-
mation in TG rats with SFBL (N 5 8) and significantly decreased
inflammation in TG EX rats (N 5 8) compared with TG SHAM controls
(N 5 5). There was no difference between TG EX and nonTG SHAM
(N 5 5). IL-1b protein concentrations (S) in the cecal tissue confirmed
decreased inflammation in TG EX vs. TG SHAM, but showed no
difference between TG SFBL and TG SHAM. *P , 0.0001 vs. all other
groups. §P , 0.002 vs. TG SFBL and P , 0.0001 vs. TG EX and nonTG
SHAM. ¶P , 0.007 vs. TG EX and nonTG SHAM.
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Figure 3. Histological evidence of cecal inflammation in HLA-B27/b2 micro-
globulin TG rats exposed to variable bacterial loads (original magnification
4003, except D). (A) TG SHAM rat showing diffuse mucosal inflammation and
hyperplasia. (B) TG rat with an excluded cecum shows no evidence of mucosal
or submucosal inflammation. (C) TG SFBL rat developed mucosal ulceration
and submucosal inflammation. (D) TG SFBL under lower magnification (1003)
demonstrating extension of submucosal inflammation away from the ulcer.
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tectable cecal thickening (gross score, 1.3 6 0.4) but had
only very mild inflammation by histological criteria
(0.6 6 0.1, nonsignificant vs. TG EX and P , 0.02 vs.
nonTG SHAM). By histology this thickening was caused
by muscular hypertrophy and mild submucosal edema.
IL-1b protein concentrations were not elevated in the
nonTG SFBL group (83.9 6 22.2), confirming the lack
of active inflammation.
These results show a consistent increase in cecal
inflammation in TG rats with a SFBL and a virtual
absence of inflammation in the excluded cecum by gross,
histological, and biochemical parameters.
TG SFBL rats treated with metronidazole had signifi-
cantly less cecal inflammation than water controls, as
shown by blinded histology score (2.4 6 0.1 vs. 3.5 6
0.4; P , 0.05).
Colitis
There was no gross evidence of inflammation in
the colon in TG EX and nonTG SHAM rats (0.0 6 0.0
for both; P , 0.005 vs. TG SHAM) by blinded
examination. TG SFBL rats had slightly more colonic
inflammation than TG SHAM (2.0 6 0.2 vs. 1.1 6 0.3;
P , 0.05). Histological evidence of colitis was also
reduced in the TG EX compared with TG SHAM (1.1 6
0.2 vs. 1.8 6 0.1; P , 0.05), but was significantly higher
than nonTG SHAM controls (0.1 6 0.1; P , 0.01).
There was no significant difference between histological
inflammatory scores in the TG SFBL (2.2 6 0.2) and TG
SHAM groups. Grossly and histologically there was no
colitis in the nonTG SFBL group (0.2 6 0.1 and 0.3 6
0.2), respectively. These results indicate that alterations
in cecal bacterial loads can affect inflammation in the
distal colon.
Gastritis
Antral gastritis, with mucosal thickening and
mononuclear cell infiltration predominantly in the basal
two thirds of the crypts, was a consistent histological
feature in TG SHAM and SFBL rats (histological score,
2.6 6 0.1 vs. 2.5 6 0.1; NS). Surprisingly, gastritis was
significantly decreased in the TG EX group (0.4 6 0.2;
P , 0.0005) and totally absent in some of these animals.
There was no gastritis in nonTG SFBL animals (0.1 6
0.1).
Hematologic Features
TG SFBL rats had higher peripheral WBC counts
(21.6 6 1.1 vs. 15.7 6 2.1; P , 0.02) than TG SHAM,
whereas TG EX had almost normal WBC counts (8.8 6
1.0; P , 0.01 vs. TG SHAM). NonTG SFBL rats had
slightly elevated WBC counts (12.0 6 1.3; P , 0.03 vs.
TG EX and nonTG SHAM; NS vs. TG SHAM). There
was no difference in hemoglobin and hematocrit values
between the groups (data not shown).
Microbial Results
In SHAM rats (Table 1) the total, microscopically
visible number of bacteria per milliliter luminal contents
in the stomach, jejunum, and ileum was 1 log less than in
the cecum and colon. Aerobically cultivable bacteria had
the lowest concentrations in the jejunum and highest
concentrations in the cecum and colon. Our results show
a luxurious presence of bacteria in the rat stomach.
Bacteria in the stomach and jejunum were predominantly
gram-positive rods and coccobacilli; in addition, spore-
forming rods were present in the ileum. The microscopic
picture of the cecal bacteria was quite complex, yet
similar to the colon, dominated by gram-positive bacilli
and spore-forming rods with less frequent gram-negative
bacilli. Using selective culture media, concentrations of
presumed Bacteroides spp. were 3–6 logs higher in the
cecum and colon compared with the jejunum and ileum.
One of 3 rats had no detectable (,102/mL) Bacteroides
spp. in the stomach.
In TG and NT rats the concentrations of total visible
bacteria in the cecal contents were equal between the
SFBL and SHAM groups (Table 2). However, the number
of bacteria recovered under anaerobic growth conditions
(obligate and facultative anaerobes) was significantly
increased in the SFBL group, whereas bacteria recovered
under aerobic growth conditions (aerobes and facultative
anaerobes) in the SFBL group were significantly de-
creased compared with the SHAM group. Thus, the ratio
Table 1. Bacterial Concentrations From Various Regions of TG and NonTG Rat Gastrointestinal Tract
Stomach Jejunum Ileum Cecum Colon
Total count (organism/mL) 0.5–1.6 3 1012 3–8 3 1011 2–3 3 1011 3–4 3 1012 3 3 1012
Anaerobic culture (CFU/mL) 4–6 3 109 3–6 3 108 3–5 3 109 0.2–2 3 1010 0.5–1 3 1010
Aerobic culture (CFU/mL) 0.4–2.5 3 109 1–5 3 107 3–8 3 108 0.2–2.7 3 109 0.4–3.8 3 109
Bacteroides spp. (CFU/mL) 0–1 3 105 2–4 3 102 0.1–1 3 105 0.4–2 3 108 1–3 3 108
NOTE. Results are expressed in organisms/mL luminal contents for the total count and in CFU/mL for the cultures. After serial dilutions of the
luminal contents, the total number of microscopically visible bacteria, colonies grown on MM10 agar under anaerobic conditions, colonies grown
on BHI enriched agar under aerobic conditions, and colonies grown on BBE agar under anaerobic conditions, which permits selective growth of
Bacteroides spp., were counted. Results are expressed as the range of 3 experiments.
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of anaerobically cultured bacteria to aerobically grown
organisms in the SFBL rats was almost 3 logs higher than
that of the SHAM group. Similarly, the concentrations of
isolates on the Bacteroides selective media were signifi-
cantly higher in the SFBL rats compared with the SHAM
group, and the ratio of cecal Bacteroides spp. to aerobically
grown bacteria was almost 5 logs higher in the SFBL
group (Table 2). The dominant Bacteroides spp. were B.
fragilis and B. vulgatus, present in approximately equal
frequencies, with no difference in the relative frequency
of these strains in SFBL vs. SHAM rats. Rats from the TG
EX group had 2–3 log decreased total and viable cecal
bacterial concentrations and 2 log fewer Bacteroides spp. in
the cecum compared with SHAM. In TG SFBL rats
treated with metronidazole no Bacteroides spp. were
detectable in cecal contents. Although total bacterial
concentrations per milliliter cecal contents were similar
between the SFBL and SHAM groups, the enlarged ceca
of SFBL rats were considerably heavier (Table 2) because
of increased luminal contents and the thickened cecal
walls, leading to much higher bacterial loads in the SFBL
ceca.
The total concentrations of bacteria in the stomach and
colon were not different between the groups (SHAM,
SFBL, EX; data not shown).
Discussion
These data emphasize the important role of lumi-
nal resident bacteria in the pathogenesis of spontaneous
colitis in HLA-B27 transgenic rats by showing that the
degree of local cecal inflammation depends on the
luminal bacterial load and composition in this genetically
susceptible host. In the excluded cecum both the bacte-
rial concentration and total bacterial load are decreased,
with a corresponding decrease in inflammation. However,
although the overall bacterial concentration is normal in
the cecal blind loop, the total load of bacteria is increased,
because of the higher volume of cecal contents, as
manifested by cecal weight, and is associated with more
aggressive mucosal and submucosal inflammation. How-
ever, cecal inflammation is not exclusively dependent on
the bacterial load, because disease fails to develop in the
blind loop of nonTG rats, showing a corequirement of
host genetic susceptibility. These findings are consistent
with previous observations in several different models.
Lichtman et al. induced hepatobiliary inflammation and
arthritis in genetically susceptible Lewis rats by creating
small intestinal bacterial overgrowth with a jejunal
SFBL23,24 and reported pouchitis in Lewis rats with an
ileal pouch–rectal anastomosis.29 Each of these models
were related to bacterial overgrowth of predominantly
anaerobic bacteria, including Bacteroides spp., and re-
sponded to metronidazole treatment, which eliminated
Bacteroides spp.23,25,29 Similarly, proximal diversion of the
fecal stream by ileostomy induces remission in Crohn’s
disease, reduces steroid requirements, and prevents post-
operative disease recurrence, but symptoms recur soon
after reestablishing intestinal continuity20,21,30 or infu-
sion of luminal contents.31
The ratio of anaerobic to aerobic bacteria and the
concentration of Bacteroides spp. seem to be additional
determinants of inflammation. Although the luminal
concentration of cultivable anaerobic bacteria in SFBL
rats was only slightly increased by 1 log, the number of
aerobically grown bacteria was decreased by 2 logs.
Therefore, the ratio of anaerobic (which includes obligate
and facultative anaerobes) to facultative anaerobic bacte-
ria was up to 1000-fold higher in the SFBL vs. SHAM
rats. The ratio of Bacteroides spp. to facultative anaerobic
bacteria was increased to an even greater degree (10,000–
100,000-fold higher in the SFBL vs. SHAM group).
Moreover, concentrations of bacteria grown in Bacteroides
Table 2. Cecal Bacterial Concentrations
NonTG (N 5 6) TG (N 5 1–2)
SFBL SHAM EX SFBL SHAM EX
Total 2–6 3 1012 3–6 3 1012 2–4 3 1010 a 2–3 3 1012 2–3 3 1012 2 3 1010
Anaerobic 2 (60.6) 3 1010 a 4 (61) 3 109 2 (61) 3 106 2–4 3 1010 3–4 3 109 5 3 108
Aerobic 7 (63) 3 106 a 9 (64) 3 108 2 (60.4) 3 106 2–6 3 107 2–3 3 109 4 3 107
Bacteroides spp. 9 (64) 3 109 a 2 (60.8) 3 107 4 (60.4) 3 105 2 3 109 4 3 107 ND
Ratio anaerobic/aerobic 2846 6 2186a 5 6 2.5 1 6 0.3 333–2000 1–2 13
Ratio Bacteroides spp./aerobic 1703 6 815a 0.02 6 0.007 0.2 6 0.1 33–100 0.01–0.02 ND
Cecal weight including contents ND ND ND 14.8 g 4 g 1.5 g
NOTE. Results are expressed in organisms/mL luminal contents for the total count and in CFU/mL for the cultures using the techniques described
in Table 1. After serial dilutions in phosphate-buffered saline or prereduced thioglycolate, cecal contents were cultured anaerobically on MM10,
PRAS, and BBE agar plates and aerobically on enriched BHI and blood agar plates. Results of transgenic and microscopic counts of nonTG rats are
expressed as the range of 1–2 experiments. Culture results of nonTG rats (n 5 6) are expressed as mean values.
ND, not done.
aP , 0.05 vs. nonTG SHAM.
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selective media in the cecum and colon of the SHAM
group were 5–6 logs higher than in the proximal small
intestine. Although the selected BBE agar probably does
not recover all Bacteroides and we were able to recover 1%
or less of organisms observed by phase-contrast micros-
copy, an equal percentage of organisms should be recov-
ered in all groups. Total bacterial concentrations were 2
logs lower in the colon of the EX group compared with
SHAM rats. Anaerobic bacteria, especially Bacteroides
spp., have been incriminated in the pathogenesis of
Crohn’s colitis and experimental colitis by earlier studies.
Fecal concentrations and serum antibodies to anaerobic
bacteria, such as Bacteroides, Eubacteria, and Peptostreptococ-
cus, are increased in Crohn’s disease.2,32–35 Furthermore,
patients with Crohn’s disease have increased mucosal
antibodies against luminal bacteria, including Bacteroides
spp.36 Metronidazole, which is selectively active against
anaerobic bacteria and which can chronically suppress
Bacteroides spp.,37 is effective in Crohn’s colitis and
ileocolitis,16 in spontaneous colitis in B27 TG rats,18 and
in indomethacin-induced chronic intestinal inflamma-
tion4 and prevents hepatobiliary injury and arthritis
associated with small bowel bacterial overgrowth in the
jejunal SFBL model.23,25 In the jejunal SFBL model,
metronidazole and tetracycline had very little effect on
total bacterial concentrations but eliminated Bacteroides
spp., whereas gentamycin and polymyxin B had no effect
on Bacteroides concentrations and exhibited no protective
benefit on inflammation.25 Similarly, we show that
metronidazole attenuates local inflammation in the cecal
SFBL model and eliminates detectable Bacteroides spp. B.
vulgatus has been incriminated in the pathogenesis of
HLA-B27 TG rats12 and carrageenan-induced colitis in
guinea pigs5 by reconstitution studies. In addition, Cong
et al.11 documented CD41 T cell responses to B. vulgatus
in C3H/HeJ Bir mice. Furthermore, Garcia-La Fuente et
al.38 recovered B. fragilis and B. uniformis from inflamed
colonic walls after trinitrobenzene sulfonic acid treatment
in rats and showed that anaerobes played a key role in
transmural inflammation in this model. In the present
study, we found B. vulgatus and B. fragilis to be the
dominant Bacteroides spp. Although Bacteroides spp. ap-
peared to be involved in cecal inflammation, other
anaerobes and even aerobes contribute to the inflamma-
tory response, because metronidazole eliminated de-
tectible Bacteroides spp. but did not completely eliminate
cecal inflammation. However, anaerobic bacteria seem to
play only a minor role in ulcerative colitis2 and antibiot-
ics are not effective with the exception of ciprofloxacin.39
Although spontaneous colitis in HLA-B27 TG rats more
closely resembles ulcerative colitis than Crohn’s disease,
the presence of focal mucosal ulcerations and transmural
inflammation in the presence of increased bacterial loads
following creation of an SFBL suggests a Crohn’s-like
pattern. Furthermore, the TH1 profile of cytokines in
HLA-B27 TG rats12 more closely resembles Crohn’s
disease than ulcerative colitis.40
Gastritis is a common feature in several colitis mod-
els7,12,41 and is found in up to 60% of Crohn’s disease
patients after careful investigation.42 Surprisingly, gastri-
tis in TG rats seems to be more dependent on cecal than
gastric bacterial loads. EX and SHAM rats had equal
bacterial concentrations in the stomach, yet gastritis was
significantly reduced in the EX group and completely
absent in some of these animals. We hypothesize that
exposure to anaerobic bacteria, such as Bacteroides spp.,
increases mucosal uptake of bacterial components in the
cecum, which contains large lymphoid aggregates.43 This
uptake of bacteria and bacterial antigens stimulates
mucosal lymphocytes, which then circulate and home to
different mucosal sites, such as the colon and stomach,
where in the rat the total bacterial load is higher than in
the jejunum and ileum. This hypothesis is supported by
observations that enterotoxins secreted by several B.
fragilis spp. increases epithelial permeability and bacte-
rial internalization by HT-29 enterocytes,44 small bowel
bacterial overgrowth enhances mucosal uptake of the
bacterial cell wall polymer peptidoglycan-polysaccharide
(PG-PS),26 and the homing of mucosal lymphocytes in
SCID mice is dependent on enteric bacteria.9 Further-
more, this concept is consistent with suppression of
colitis in T cell receptor (TCR)-a deficient mice by
resection of the cecal tip (‘‘appendix’’), which contains a
large lymphoid aggregate.43 Although our results agree
in principle with those of Mizoguchi et al.43 in which
early ‘‘appendectomy’’ prevented the onset of colitis in
TCR-a knockout mice for up to 6 months, the present
study includes several important new advances in knowl-
edge. (1) The influence of the cecum on inflammation in
the stomach, an even more remote organ than the colon,
further supports the concept of local T-cell induction in
the cecum followed by lymphocyte trafficking to remote
sites. (2) Microbial assessments strongly implicate nor-
mal cecal luminal bacteria in the pathogenesis of local
inflammation in the cecum and in remote organs such as
the stomach, because the excluded cecum had 2 logs less
of cecal bacteria but equal gastric bacteria compared with
SHAM controls. In contrast, cecal overgrowth of anaero-
bic bacteria dramatically aggravates the local inflamma-
tion but does not influence gastritis. (3) Appendectomy
in the TCR-a knockout mice was performed at 3 weeks
of age (before the onset of colitis) and prevented colitis for
6 months,43 whereas the exclusion of the cecum in B27
TG rats was performed at 2 months of age (after the onset
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of gastrointestinal inflammation) and therefore treated
established colitis and gastritis. In contrast, appendec-
tomy performed after 5 weeks of age did not prevent
colitis in TCR-a mice.43 Of interest, luminal bacterial
stimulation also appears to influence colitis in TCR-a–
deficient mice as evidenced by development of an
oligoclonal immune response to cecal bacteria45 and
absence of colitis in a sterile environment.46
An alternative, but less likely, explanation of the
remote inflammation is that cytokines and soluble inflam-
matory mediators secreted by the inflamed cecal mucosa
cause antral mucosal injury. Therefore, in the absence of
cecal inflammation, systemic cytokine concentrations
could be lower than controls. The lack of enhanced
gastritis with significantly more aggressive cecal inflam-
mation with cecal bacterial overgrowth in SFBL TG rats
makes this explanation less likely.
Systemic manifestations such as arthritis and leukocy-
tosis, which were more pronounced in the SFBL group,
are probably caused by increased mucosal absorption of
proinflammatory bacterial products such as lipopolysac-
charide (LPS) and PG-PS, or translocation of viable
bacteria.2 In the jejunal SFBL model small intestinal
bacterial overgrowth causes hepatobiliary injury,24 reacti-
vates quiescent arthritis in genetically susceptible Lewis
rats,23 and leads to bacterial translocation into mesenteric
lymph nodes24 and systemic absorption of LPS47 and
PG-PS.24,26 Furthermore, systemic endotoxemia occurs in
trinitrobenzene sulfonic acid– and acetic acid–induced
colitis,48,49 and correlates with disease activity in ulcer-
ative colitis and Crohn’s disease.50 It was somewhat
surprising that arthritis occurred only in 1 of 8 TG rats
with a cecal SFBL. There might be two explanations: (1)
arthritis and hepatobiliary injury in the jejunal SFBL
model was induced in genetically susceptible Lewis
rats,23 whereas our TG rats are on the resistant Fischer
background24; and (2) arthritis in B27 TG Fischer rats in
our SPF environment is mild, inconsistent, and follows an
undulating pattern with a very late onset.12 Our rats were
killed at 3 months of age corresponding with the earliest
onset of arthritis in this model.14 A mild degree of
leukocytosis is expected in B27 TG rats.12,13 The in-
creased leukocytosis in the TG SFBL group is consistent
with our previous observations that TG rats with a
jejunal SFBL had higher WBC counts than TG rats
without surgery.51
This study emphasizes the direct influence of the cecal
anaerobic bacterial load, especially Bacteroides spp., and
the ratio of anaerobic to aerobic bacteria on local
inflammation in the cecum, because the degree of
inflammation correlates with levels of isolates on Bacteroides-
selective medium and increased anaerobic/aerobic and Bacteroi-
des/aerobic ratios and cecal inflammation was attenuated by
metronidazole, which dramatically decreased cecal Bacteroides
concentrations. Moreover, it shows that the cecal bacterial load
influences remote inflammation in the distal colon, stomach,
and bone marrow through as yet undefined mechanisms.
These results have important therapeutic implications for
human inflammatory bowel diseases that may extend past the
established approaches of bowel rest and antibiotic therapy.
Future studies should focus on more specific antimicrobial
therapeutic protocols targeting anaerobic bacteria and Bacteroi-
des spp., on blockade of membrane receptors for PG-PS, LPS,
and chemotactic peptides from anaerobes, on enhancing
luminal growth of protective bacteria competing for anaerobic
niches, and on direct immunologic approaches targeting
Bacteroides antigens.
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